SecBot SecBot
SECBOTREPLAY Home › Report › ELV

ELV · Elevance Health reported Q2 2026 adjusted EPS of $7.45, a 20% beat vs…

Elevance Health, Inc. · 8-K filed Jul 15, 2026 at 06:01 ET

At the news

MIXEDIMPACT 6/10

8-K filed Jul 15, 2026 at 06:01 ET

Elevance Health reported Q2 2026 adjusted EPS of $7.45, a 20% beat vs consensus of $6.21, and raised full-year adjusted EPS guidance to at least $27.00. Operating revenue grew just 0.8% YoY to $49.8B, while GAAP EPS fell 13.1% and adjusted EPS fell 15.7% YoY, with benefit expense ratio rising 80bp to 89.7% and operating margin compressing to 3.5%. The beat and guidance raise are positive, but declining membership and margin pressure temper the outlook.

  • Q2 2026 adjusted EPS $7.45 vs consensus $6.21 (beat by 20.0%)
  • Q2 2026 operating revenue $49.8B vs consensus $48.63B (beat by 2.4%)
  • FY2026 adjusted EPS guidance raised to at least $27.00 (from at least $26.75)
  • FY2026 GAAP EPS guidance raised to at least $20.10 (from at least $19.85)

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access